New Solution for Small RNA Discovery Enables New Experiments for Understanding Critical Biological and Disease Processes FOSTER CITY, Calif.–Only in recent years have scientists begun to understand the role of small, non-protein coding RNA molecules in living cells. Breakthroughs in science and technology have revealed that this newly discovered class of regulatory molecules plays a […]
SAN DIEGO–Illumina, Inc. (NASDAQ:ILMN – News) today announced that it has reorganized its operating structure to further leverage the synergies between its sequencing and genotyping businesses. Under the new structure, a newly created Life Sciences Business Unit will include all products and services related to the research market namely the BeadArray, BeadXpress and Sequencing product […]
CAMBRIDGE, Mass.–Helicos BioSciences Corporation (Nasdaq: HLCS – News) announced today that it has priced its initial public offering of 5,400,000 shares of common stock at $9.00 per share. All of the common stock is being offered by the company, and the common stock will trade on the NASDAQ Global Market under the symbol “HLCS.” The […]
Roche and CuraGen today announced that they have signed a definitive agreement under which Roche will acquire 100% of 454 Life Sciences, a majority-owned subsidiary of CuraGen Corporation, active in high-throughput DNA sequencing. Under the terms of the agreement, Roche will pay 454 Life Sciences’ shareholders USD 140 million in cash. In addition to the […]
Combined company to develop platform for sequencing human genomic DNA at markedly reduced cost PROVIDENCE, R.I.–NABsys, Inc. and GeneSpectrum, Inc. announced today that NABsys has acquired GeneSpectrum in an all-stock transaction. The combined company, NABsys, will pursue its proprietary Hybridization-Assisted Nanopore Sequencing (HANS) platform for sequencing human genomic DNA. “The data and expertise that GeneSpectrum […]
SAN DIEGO & HAYWARD, Calif.–Illumina, Inc. (NASDAQ: ILMN – News) and Solexa, Inc. (NASDAQ: SLXA – News) announced today that they have entered into a definitive merger agreement under which Illumina will acquire Solexa in a stock-for-stock merger. Under the merger agreement, which was unanimously approved by the Boards of Directors of both companies, Solexa’s […]
BRANFORD, Conn.,– 454 Life Sciences Corporation, a majority-owned subsidiary of CuraGen Corporation (Nasdaq: CRGN), and Roche Diagnostics today announced the launch of an updated version of the Genome Sequencer 20(TM) System. Version 1.02 of the Genome Sequencer 20 System comes with a bundle of improvements. The most important new features are: * a single read […]
Applied Biosystems (NYSE:ABI), an Applera Corporation business, today announced at the 2006 Annual Meeting of the American Association for Cancer Research (AACR) that it has entered into a collaboration with the Core Genotyping Facility, SAIC-Frederick, Inc., a contractor for the National Cancer Institute (NCI), on a series of biomarker studies for cancer research. The NCI-funded […]
Melbourne, Australia-Genetic Technologies (GTC) has reached a final settlement with Applera, resulting in binding agreements, and a license for Applera to use GTC’s patents covering non coding regions of the human genome. In 2003, GTC filed suit against Applera for infringement of its US Patent No. 5,612,179. (Intron Sequence Analysis Method for Detection of Adjacent […]
Next Generation Sequencing Technology May Hold Promise of the $1,000 Genome FOSTER CITY, Calif. & HOUSTON–Applied Biosystems Group (NYSE:ABI), an Applera Corporation business, and VisiGen Biotechnologies, Inc., announced today that Applied Biosystems has signed a definitive agreement to make an equity investment in privately held VisiGen, a next-generation sequencing technology company, and to enter into […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
